HIF‐1α increases RANKL expression in stromal fibroblasts,(38) breast cancer cells,(39) and osteocytic MLO‐Y4 cells.(40) HIF‐2α deficiency in mice enhances bone mass, in part by inhibiting osteoclastogenesis. Here, HIF1A is linked to breast carcinoma.